ArticleBMC cancer2024

Immune checkpoint inhibitor plus chemotherapy as first-line treatment for non-small cell lung cancer with malignant pleural effusion: a retrospective multicenter study.

Qi Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.